T-705 (Favipiravir)
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
Important Notice: For research use only. We do not sell to patients.
Loading distributor info...
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
Important Notice: For research use only. We do not sell to patients.
Loading distributor info...
Discription | T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo. |
||
---|---|---|---|
Targets |
|
Catalog Num | A11590 |
---|---|
Formula | C5H4FN3O2 |
Molecular Weight | 157.1 |
CAS Number | 259793-96-9 |
SMILES | C1=C(N=C(C(=O)N1)C(=O)N)F |
Synonyms | T705, T 705 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 29 mg/mL (184.59 mM) | |
Water | Warmed: 5 mg/mL (31.82 mM) | ||
Ethanol | Warmed: 21 mg/mL (133.67 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 63.65 mL | 318.27 mL | 636.54 mL |
0.5 mM | 12.73 mL | 63.65 mL | 127.31 mL |
1 mM | 6.37 mL | 31.83 mL | 63.65 mL |
5 mM | 1.27 mL | 6.37 mL | 12.73 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2